Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CROCC2 (Ciliary rootlet coiled-coil protein 2) is a human-specific protein of 111 amino acids arising from partial duplication of the rootletin (CROCC) gene. It is primarily expressed during human brain development, especially in the fetal cortex, and not in other primate species. CROCC2 regulates ciliary length and dynamics by interacting with the ciliary trafficking protein IFT20, leading to altered neurogenesis through increased mTOR signaling and expansion of basal cortical progenitors. Its function highlights a species-specific role in the evolution of human cortical development. No direct therapeutic applications or disease associations are documented, though its biology may inform future research into neurodevelopmental disorders[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliary rootlet coiled-coil protein 2 (CROCC2).